Physician profile
Jacob Scott
NPI 1801314356
$3,954.55
in general payments reported to CMS, 2019-2025
18 companies · $1,624 in 2025
The $1,624 reported for 2025 was more than what 89% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $930 · 2022: $247 · 2023: $569 · 2024: $585 · 2025: $1,624.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,770 · Education: $7.52.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,770.03 |
| Education | $7.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $801.77 | 2023-2025 | Qelbree, Qelbree |
| Abbvie INC. | $696.21 | 2021-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $627.21 | 2021-2025 | Caplyta |
| Otsuka America Pharmaceutical, INC. | $349.86 | 2021-2025 | Rexulti, Abilify Maintena |
| Vanda Pharmaceuticals INC. | $314.95 | 2021-2025 | Fanapt |
| Axsome Therapeutics, INC. | $293.19 | 2023-2025 | Auvelity, Sunosi |
| Janssen Pharmaceuticals, INC | $229.06 | 2022-2025 | Spravato |
| Corium, LLC | $215.56 | 2023-2025 | Azstarys |
| Alkermes, INC. | $115.44 | 2021-2025 | Aristada, Lybalvi |
| Takeda Pharmaceuticals U.S.A., INC. | $78.47 | 2021 | |
| Sunovion Pharmaceuticals INC. | $59.25 | 2021 | |
| Lundbeck LLC | $45.93 | 2021-2023 | Rexulti |
| Harmony Biosciences LLC | $42.74 | 2025 | |
| Eisai INC. | $18.65 | 2021 | |
| Collegium Pharmaceutical, INC. | $17.82 | 2025 | Jornay Pm |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $16.91 | 2025 | Dyanavel Xr |
| Almatica Pharma LLC | $16.18 | 2024 | Loreev Xr |
| Dentsply Sirona INC | $15.35 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacob Scott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.